AbbVie Inc. (ABBV) Financial Statements (2024 and earlier)

Company Profile

Business Address 1 NORTH WAUKEGAN ROAD
NORTH CHICAGO, IL 60064
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments13,2908,7666,7229,22911,8799,961
Cash and cash equivalents13,2878,7596,7119,20111,8328,521
Short-term investments371128471,440
Receivables11,41211,49111,47311,25410,74311,237
Inventory, net of allowances, customer advances and progress billings3,9814,0553,8333,5793,1723,396
Inventory3,9814,0553,8333,5793,1723,396
Other undisclosed current assets4,5414,5404,4604,4014,5704,506
Total current assets:33,22428,85226,48828,46330,36429,100
Noncurrent Assets
Property, plant and equipment4,9344,9434,9314,9354,8934,958
Long-term investments and receivables275288257241235244
Long-term investments275288257241235244
Intangible assets, net (including goodwill)90,69495,08697,06899,595100,451103,851
Goodwill32,09132,22432,22032,15631,72632,028
Intangible assets, net (excluding goodwill)58,60362,86264,84867,43968,72571,823
Other noncurrent assets7,0946,1985,8005,5715,3825,033
Total noncurrent assets:102,997106,515108,056110,342110,961114,086
TOTAL ASSETS:136,221135,367134,544138,805141,325143,186
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:29,65827,03624,78925,40223,50522,543
Accounts payable   2,934  
Accrued liabilities   10,282  
Other undisclosed accounts payable and accrued liabilities29,65827,03624,78912,18623,50522,543
Debt5,1155,2032,8014,1369,20711,930
Total current liabilities:34,77332,23927,59029,53832,71234,473
Noncurrent Liabilities
Long-term debt and lease obligation, including:55,63155,81259,29259,13560,39961,002
Finance lease, liability   17  
Other undisclosed long-term debt and lease obligation55,63155,81259,29259,11860,39961,002
Liabilities, other than long-term debt33,68834,41834,35932,84532,18733,023
Deferred income tax liabilities2,0442,1242,1102,1901,9722,255
Other liabilities31,64432,29432,24930,65530,21530,768
Total noncurrent liabilities:89,31990,23093,65191,98092,58694,025
Total liabilities:124,092122,469121,241121,518125,298128,498
Equity
Equity, attributable to parent, including:12,09412,86613,27417,25415,99414,653
Treasury stock, value(6,525)(6,528)(6,524)(4,594)(4,590)(4,591)
Additional paid in capital20,02119,83919,61919,24519,05618,906
Accumulated other comprehensive loss(2,353)(2,252)(2,232)(2,199)(3,443)(3,196)
Retained earnings (accumulated deficit)9331,7892,3934,7844,9533,516
Other undisclosed equity, attributable to parent181818181818
Equity, attributable to noncontrolling interest353229333335
Total equity:12,12912,89813,30317,28716,02714,688
TOTAL LIABILITIES AND EQUITY:136,221135,367134,544138,805141,325143,186

Income Statement (P&L) ($ in millions)

12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
Revenues13,92713,86512,22515,12114,81214,583
Cost of revenue(6,485)(4,240)(3,986)(4,169)(5,251)(4,170)
Cost of goods and services sold(6,485)(4,240)(3,986)(4,170)(5,022)(4,170)
Gross profit:7,4429,6258,23910,9529,56110,413
Operating expenses(5,161)(5,281)(5,481)(5,450)(4,958)(7,290)
Other operating income (expense), net  169101(229)172
Other undisclosed operating income (loss)    (1)229 
Operating income:2,2814,5132,7685,5024,6033,295
Nonoperating income (expense)227(1,351)(1,740)(1,971)357(1,556)
Investment income, nonoperating1579899906324
Other nonoperating income (expense)95(1,412)(1,804)(2,021)330(1,533)
Interest and debt expense(555)(552)(553)(566)(560)(556)
Income from continuing operations before income taxes:1,9532,6104752,9654,4001,183
Income tax expense(172)(583)(234)(493)(448)(255)
Income from continuing operations:1,7812,0272412,4723,952928
Income before gain (loss) on sale of properties:3,952928
Net income:1,7812,0272412,4723,952928
Net income (loss) attributable to noncontrolling interest(3)(3)(2)1(3)(4)
Net income attributable to parent:1,7782,0242392,4733,949924
Other undisclosed net loss available to common stockholders, basic(11)(11)(11)(11)(18)(11)
Net income available to common stockholders, diluted:1,7672,0132282,4623,931913

Comprehensive Income ($ in millions)

12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
Net income:1,7812,0272412,4723,952928
Other comprehensive income (loss)(101)(20)(33)1,244(247)(212)
Comprehensive income:1,6802,0072083,7163,705716
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(3)(3)(2)1(3)(4)
Comprehensive income, net of tax, attributable to parent:1,6772,0042063,7173,702712

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: